Clinical Nutrition in Metabolic and Cardiovascular Diseases | Metabolic Support Treaty

Clinical Nutrition · Clinical Specialties

How it begins

A comprehensive molecular analysis of metabolic support and medical nutritional therapy across the cardiometabolic risk spectrum. This treatise integrates the biochemistry of insulin cellular signaling, low-grade systemic inflammation, lipid profile modulation, and enteral and parenteral therapy aimed at critically ill and chronic patients.

What it covers

1. Nutrition and Cardiometabolic Diseases
2. Metabolic Syndrome and Pathophysiology of Insulin Resistance
3. · 1.1 · Molecular Cascade of the Insulin Receptor and IRS-1
4. · 1.2 · Low Grade Systemic Inflammation (Metaininflammation)
5. Medical Nutritional Therapy in Type 2 Diabetes Mellitus (T2DM)
6. · 2.1 · Carbohydrate Kinetics: Glycemic Index vs. Glycemic Load
7. · 2.2 · Insulin Dosing Therapy and Carbohydrate Counting
8. · 2.3 · Critical Drug-Nutrient Interactions (SGLT-2i and GLP-1 RA)
9. Obesity, Adiposopathy and Structured Energy Restriction
10. · 3.1 · Adipokines and Physiopathology of Hunger and Satiety
11. · 3.2 · Nutritional Approach: Ketogenic Diet vs. Intermittent Fasting
12. Dyslipidemias and Nutritional Pathophysiology of Atherogenesis
13. · 4.1 · Dynamics of Saturated, Monounsaturated and Polyunsaturated Fatty Acids
14. · 4.2 · Phytosterols and Soluble Fiber in the Interruption of Enterohepatic Circulation
15. High Blood Pressure and Nutritional Physiology of the DASH Diet
16. · 5.1 · The Sodium-Potassium Exchanger and Vascular Reactivity
17. · 5.2 · Sodium Restriction in Sodium-Sensitive Patients
18. Heart Failure and Pathophysiology of Cardiac Cachexia
19. · 6.1 · Metabolic Remodeling of the Insufficient Myocardium
20. · 6.2 · Depletion of Essential Micronutrients by Pharmacotherapy
21. Diabetic Kidney Disease (DKD) and Nutritional Nitrogen Management
22. · 7.1 · Glomerular Hemodynamics and Hyperfiltration
23. · 7.2 · Low Protein Diet and Preservation of Nitrogen Balance
24. · 7.3 · Electrolyte Homeostasis in Advanced ERD
25. Nutritional Therapy in Post-Infarction Ischemic Heart Disease
26. · 8.1 · Pathophysiology of Ischemia-Reperfusion Injury
27. · 8.2 · Anti-inflammatory Diet and Modulation of Matrix Metalloproteinases
28. Endothelial Dysfunction, Oxidative Stress and Vascular Nutraceuticals
29. · 9.1 · Biochemistry of Endothelial Barrier Damage
30. · 9.2 · Application of Precision Nutraceuticals
31. Pathophysiology and Prevention of Refeeding Syndrome
32. · 10.1 · Transition from Starvation State to Sudden Anabolism
33. · 10.2 · Clinical Consequences of Extreme Hypophosphatemia
34. Artificial Nutritional Support in the Critical Cardiovascular Patient
35. · 11.1 · Mechanical Ventilation and Enteral Nutrition in Cardiogenic Shock
36. · 11.2 · Specialized Formulas for Cardiovascular and Pulmonary Pathologies
37. Intestinal Microbiota, Bacterial Metabolites and Cardiovascular Risk
38. · 12.1 · Biochemical Route of the Synthesis of TMAO (Trimethylamine N-Oxide)
39. · 12.2 · The Protective Role of Short Chain Fatty Acids (SCFAs)
40. Pharmaconutrition, Nutrigenomics and Advanced Nutraceuticals
41. · 13.1 · Interaction of Omega-3 Fatty Acids with the GPR120/FFA4 Receptor
42. · 13.2 · Nutrigenomics of the ApoE Gene and Response to Dietary Fat
43. · 13.3 · Precision Pharmaconutrient Profile
44. Multidisciplinary Clinical Approach and Nutritional Transition Plan
45. · 14.1 · Transition Protocol from Parenteral to Enteral / Oral Nutrition
46. · 14.2 · Post-Discharge Ambulatory Follow-up Algorithm for Cardiometabolic Patients
47. · 14.3 · Conclusions and Fundamental Principles of the Treaty